Allison Joyce
Overview
Explore the profile of Allison Joyce including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
668
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma Y, Joyce A, Brandenburg O, Saatchi F, Stevens C, Tcheuyap V, et al.
Clin Cancer Res
. 2022 Oct;
28(24):5405-5418.
PMID: 36190432
Purpose: HIF2α is a key driver of kidney cancer. Using a belzutifan analogue (PT2399), we previously showed in tumorgrafts (TG) that ∼50% of clear cell renal cell carcinomas (ccRCC) are...
2.
Loayza Mafayle R, Morales-Betoulle M, Romero C, Cossaboom C, Whitmer S, Alvarez Aguilera C, et al.
N Engl J Med
. 2022 Jun;
386(24):2283-2294.
PMID: 35704480
Background: In June 2019, the Bolivian Ministry of Health reported a cluster of cases of hemorrhagic fever that started in the municipality of Caranavi and expanded to La Paz. The...
3.
Malenfant J, Joyce A, Choi M, Cossaboom C, Whitesell A, Harcourt B, et al.
MMWR Morb Mortal Wkly Rep
. 2022 Feb;
71(8):290-292.
PMID: 35202354
On December 19, 2019, the Food and Drug Administration (FDA) approved rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO, Merck) for the prevention of Ebola virus disease (EVD) caused by infection with Ebola virus,...
4.
Nyakarahuka L, Mulei S, Whitmer S, Jackson K, Tumusiime A, Schuh A, et al.
PLoS Negl Trop Dis
. 2022 Feb;
16(2):e0010205.
PMID: 35192613
Uganda established a domestic Viral Hemorrhagic Fever (VHF) testing capacity in 2010 in response to the increasing occurrence of filovirus outbreaks. In July 2018, the neighboring Democratic Republic of Congo...
5.
Elias R, Tcheuyap V, Kaushik A, Singla N, Gao M, Reig Torras O, et al.
Cell Rep
. 2021 Nov;
37(8):110055.
PMID: 34818533
Renal cell carcinoma (RCC) encompasses a heterogenous group of tumors, but representative preclinical models are lacking. We previously showed that patient-derived tumorgraft (TG) models recapitulate the biology and treatment responsiveness....
6.
Udayakumar D, Zhang Z, Xi Y, Dwivedi D, Fulkerson M, Haldeman S, et al.
Clin Cancer Res
. 2021 Jul;
27(17):4794-4806.
PMID: 34210685
Purpose: Intratumoral heterogeneity (ITH) challenges the molecular characterization of clear cell renal cell carcinoma (ccRCC) and is a confounding factor for therapy selection. Most approaches to evaluate ITH are limited...
7.
Choi M, Cossaboom C, Whitesell A, Dyal J, Joyce A, Morgan R, et al.
MMWR Recomm Rep
. 2021 Jan;
70(1):1-12.
PMID: 33417593
This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the rVSVΔG-ZEBOV-GP Ebola vaccine (Ervebo) in the United States. The vaccine contains rice-derived recombinant...
8.
Courtney K, Ma Y, De Leon A, Christie A, Xie Z, Woolford L, et al.
Clin Cancer Res
. 2019 Nov;
26(4):793-803.
PMID: 31727677
Purpose: The heterodimeric transcription factor HIF-2 is arguably the most important driver of clear cell renal cell carcinoma (ccRCC). Although considered undruggable, structural analyses at the University of Texas Southwestern...
9.
Wang T, Lu R, Kapur P, Jaiswal B, Hannan R, Zhang Z, et al.
Cancer Discov
. 2018 Jun;
8(9):1142-1155.
PMID: 29884728
By leveraging tumorgraft (patient-derived xenograft) RNA-sequencing data, we developed an empirical approach, DisHet, to dissect the tumor microenvironment (eTME). We found that 65% of previously defined immune signature genes are...
10.
Chen W, Hill H, Christie A, Kim M, Holloman E, Pavia-Jimenez A, et al.
Nature
. 2016 Sep;
539(7627):112-117.
PMID: 27595394
Clear cell renal cell carcinoma (ccRCC) is characterized by inactivation of the von Hippel-Lindau tumour suppressor gene (VHL). Because no other gene is mutated as frequently in ccRCC and VHL...